These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 27639107)

  • 21. Anatomical features and management of bioresorbable vascular scaffolds failure: A case series from the GHOST registry.
    Longo G; Granata F; Capodanno D; Ohno Y; Tamburino CI; Capranzano P; La Manna A; Francaviglia B; Gargiulo G; Tamburino C
    Catheter Cardiovasc Interv; 2015 Jun; 85(7):1150-61. PubMed ID: 25573598
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In-scaffold restenosis in a previous left main bifurcation lesion treated with bioresorbable scaffold v-stenting.
    Miyazaki T; Panoulas VF; Sato K; Kawamoto H; Naganuma T; Latib A; Colombo A
    JACC Cardiovasc Interv; 2015 Jan; 8(1 Pt A):e7-e10. PubMed ID: 25499306
    [No Abstract]   [Full Text] [Related]  

  • 23. Clinical outcomes following bioresorbable scaffold implantation in small vessels.
    Tanaka A; Ruparelia N; Kawamoto H; Sticchi A; Sato K; Miyazaki T; Naganuma T; Chieffo A; Carlino M; Montorfano M; Latib A; Colombo A
    Int J Cardiol; 2016 Mar; 207():59-61. PubMed ID: 26797331
    [No Abstract]   [Full Text] [Related]  

  • 24. Bioresorbable vascular scaffolds in left main coronary artery disease.
    Everaert B; Capranzano P; Tamburino C; Seth A; van Geuns RJ
    EuroIntervention; 2015; 11 Suppl V():V135-8. PubMed ID: 25983148
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Positive Vessel Remodeling and Appearance of Pulsatile Wall Motion at Long-Term Follow-Up After Bioresorbable Scaffold Implantation in a Chronic Total Occlusion.
    Tanaka A; Ruparelia N; Kawamoto H; Latib A; Colombo A
    JACC Cardiovasc Interv; 2015 Oct; 8(12):1635-7. PubMed ID: 26386767
    [No Abstract]   [Full Text] [Related]  

  • 26. Subacute thrombosis of a bioresorbable vascular scaffold implanted for recurrent in-stent restenosis.
    Rivero F; Benedicto A; Bastante T; Cuesta J; Diego G; Alfonso F
    EuroIntervention; 2015 Nov; 11(7):780. PubMed ID: 25308302
    [No Abstract]   [Full Text] [Related]  

  • 27. Bioresorbable vascular scaffolds: the promise of transience.
    Somaratne JB; Whitbourn RJ
    Intern Med J; 2013 Jun; 43(6):615-8. PubMed ID: 23745992
    [No Abstract]   [Full Text] [Related]  

  • 28. Early neoatherosclerosis after bioresorbable vascular scaffold implantation: insights from optical coherence tomography.
    Sato T; Richardt G; Abdel-Wahab M
    Coron Artery Dis; 2016 Nov; 27(7):616-7. PubMed ID: 27228185
    [No Abstract]   [Full Text] [Related]  

  • 29. Six-month outcomes of the XINSORB bioresorbable sirolimus-eluting scaffold in treating single de novo lesions in human coronary artery.
    Wu Y; Shen L; Ge L; Wang Q; Qian J; Zhang F; Yao K; Huang D; Chen Y; Ge J
    Catheter Cardiovasc Interv; 2016 Mar; 87 Suppl 1():630-7. PubMed ID: 26864162
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bioresorbable vascular scaffolds for the treatment of coronary artery disease: what have we learned from randomized-controlled clinical trials?
    Rizik DG; Hermiller JB; Simonton CA; Klassen KJ; Kereiakes DJ
    Coron Artery Dis; 2017 Jan; 28(1):77-89. PubMed ID: 27561169
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Coronary stents: novel developments.
    Stefanini GG; Taniwaki M; Windecker S
    Heart; 2014 Jul; 100(13):1051-61. PubMed ID: 24006453
    [No Abstract]   [Full Text] [Related]  

  • 32. Everolimus-eluting bioresorbable scaffold implantation for the treatment of bifurcation lesions - Implications from early clinical experience during daily practice.
    Wiebe J; Dörr O; Bauer T; Liebetrau C; Boeder N; Möllmann H; Hamm CW; Nef HM
    Cardiovasc Revasc Med; 2016; 17(5):313-7. PubMed ID: 27085220
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Conversations in cardiology--Is BVS ready for prime time? More about the absorb study.
    Kern MJ
    Catheter Cardiovasc Interv; 2016 Apr; 87(5):902-8. PubMed ID: 26649485
    [No Abstract]   [Full Text] [Related]  

  • 34. Development and receding of a coronary artery aneurysm after implantation of a fully bioresorbable scaffold.
    Nakatani S; Ishibashi Y; Suwannasom P; Grundeken MJ; Høj Christiansen E; Onuma Y; Serruys PW;
    Circulation; 2015 Feb; 131(8):764-7. PubMed ID: 25712060
    [No Abstract]   [Full Text] [Related]  

  • 35. Long-Term Clinical Outcomes After Bioresorbable Vascular Scaffold Implantation for the Treatment of Coronary In-Stent Restenosis: A Multicenter Italian Experience.
    Moscarella E; Ielasi A; Granata F; Coscarelli S; Stabile E; Latib A; Cortese B; Tespili M; Tanaka A; Capozzolo C; Caliendo L; Colombo A; Varricchio A
    Circ Cardiovasc Interv; 2016 Apr; 9(4):e003148. PubMed ID: 27059683
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Very late bioresorbable vascular scaffold thrombosis: a new clinical entity.
    Azzalini L; Al-Hawwas M; L'Allier PL
    EuroIntervention; 2015 May; 11(1):e1-2. PubMed ID: 25982486
    [No Abstract]   [Full Text] [Related]  

  • 37. Clinical outcome of patients with and without diabetes mellitus after percutaneous coronary intervention with the resolute zotarolimus-eluting stent: 2-year results from the prospectively pooled analysis of the international global RESOLUTE program.
    Silber S; Serruys PW; Leon MB; Meredith IT; Windecker S; Neumann FJ; Belardi J; Widimsky P; Massaro J; Novack V; Yeung AC; Saito S; Mauri L
    JACC Cardiovasc Interv; 2013 Apr; 6(4):357-68. PubMed ID: 23523454
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessing bioresorbable coronary devices: methods and parameters.
    Garcia-Garcia HM; Serruys PW; Campos CM; Muramatsu T; Nakatani S; Zhang YJ; Onuma Y; Stone GW
    JACC Cardiovasc Imaging; 2014 Nov; 7(11):1130-48. PubMed ID: 25459595
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bioresorbable vascular scaffolds for small vessels coronary disease: The BVS-save registry.
    Latini RA; Granata F; Ielasi A; Varricchio A; Moscarella E; Tespili M; Cortese B
    Catheter Cardiovasc Interv; 2016 Sep; 88(3):380-7. PubMed ID: 27038332
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Current status of bioresorbable scaffolds in the treatment of coronary artery disease.
    Wiebe J; Nef HM; Hamm CW
    J Am Coll Cardiol; 2014 Dec; 64(23):2541-51. PubMed ID: 25500240
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.